Top Markets
Coin of the day
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
株式のランク #30976
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
株価
$0.13577832
時価総額
$14.83M
変化(1日)
-2.63%
変化(1年)
44.13%
CA
取引 Pharmala Biotech Holdings Inc. (MDMA)

カテゴリー

Pharmala Biotech Holdings Inc.(MDMA)の配当利回りの履歴
Pharmala Biotech Holdings Inc.(銘柄コード: MDMA)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Pharmala Biotech Holdings Inc.(MDMA)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)
企業 配当利回り
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE